Vast, Complex Datasets Mastered,
Enhanced Predictive Analytics,
Actionable Insight & Tangible ROI
22nd-24th September 2015, Boston
Deliver Tangible Outcomes & Real Insights from Vast Volumes of Complex & Varied Data
Big DiP USA is back for the 3rd year running and the 2015 meeting will accelerate the development of your therapies and inform your commercial decision making through enhanced data interpretation.
With 25 case studies from the likes of Biogen, AstraZeneca, Teva, Novartis and more that demonstrate how to perform improved data analytics and extract actionable insight from growing interconnected networks, you won’t be disappointed with what’s on offer at Big DiP USA 2015.
Empower your drug development by mastering increasingly complex and manageable data sets to derive tangible value. Leverage expertise from big data professionals that are optimizing R&D efforts and strengthening commercial results.
Big DiP USA is the end to end big data analytics gathering for pharma who are actively looking for ways to improve their R&D success and maximize the commercial value of their drug product.
"This is a great event! Something that provides a much needed direction to the Big Data community."
"Big DiP is a great meeting of minds on the subject of Big Data. It attracts an excellent mix of thought leaders and fresh young thinkers." - Moderna Therapeutics